You are here: Industry Insights > Diabetes

News List

Lupin gets tentative approval from US FDA for empagliflozin tablets expresspharma
August 05, 2020
Empagliflozin tablets are used to treat type 2 diabetes mellitus as an adjunct to diet and exercise.
People at high risk of diabetes fast-tracked into prevention programme pharmatimes
July 27, 2020
People at high risk of developing type II diabetes will be fast-tracked into the Healthier You NHS Diabetes Prevention programme, on the back of research indicating that people with the condition are at significantly higher risk of dying with COVID-19.
IQVIA and JDRF collaborate to improve understanding of Type 1 Diabetes using real world data expresspharma
July 24, 2020
The collaboration will pave the way for development of a real world research platform to facilitate evidence generation in type 1 diabetes for multiple stakeholders.
Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins expresspharma
July 22, 2020
Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of basal insulins.
Bayer's finerenone hits targets in diabetes/kidney disease trial pharmatimes
July 14, 2020
Bayer's finerenone has hit key targets in a late-stage trial assessing its safety and efficacy in patients with chronic kidney disease (CKD) and type 2 diabetes.
Lupin recalls diabetes treatment drug in US expresspharma
July 13, 2020
The company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg products in the US.
Re-purposed drugs could reverse blood vessel damage in diabetes expresspharma
June 30, 2020
In a breakthrough, scientists have discovered a key mechanism that triggers changes in the blood vessels, which can eventually lead to cardiovascular disease.
Cipla and Boehringer Ingelheim to co-market three oral anti-diabetic drugs expresspharma
June 30, 2020
The two companies will help co-market three anti-diabetic drugs Oboravo (Empagliflozin), Oboravo Met (Empagliflozin+Metformin) and Tiptengio (Empagliflozin+Linagliptin).
FDA Approves Lyumjev americanpharmaceuticalreview
June 29, 2020
The U.S. Food and Drug Administration (FDA) has approved Lyumjev? (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and ...
NHS rolls out new online support for diabetes management pharmatimes
June 11, 2020
NHS England has launched new online services to allow people with diabetes to better manage their condition remotely during the coronavirus pandemic.